Skip to main content
. 2015 Nov 5;8:163–170. doi: 10.2147/PGPM.S86444

Table 3.

Prevalence of CYP2B6 predicted phenotypes in 51 HIV-infected patients

CYP2B6
Extensive metabolizer Intermediate metabolizer Slow metabolizer
Screening, n 11 17 1
Confirmation of the cause of skin rash, n 1 2 1
ADRs besides rash, n 6 7 3
Choice of next ARV, n 2 0 0
Total, n 20 26 5
Prevalence (%) 39.2 51.0 9.8

Abbreviations: ADRs, adverse drug reactions; ARV, antiretroviral drug; CYP2B6, cytochrome P 2B6; HIV, human immunodeficiency virus.